Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver

... Read more

Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver

... Read more

Biostar

... Read more

Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and

... Read more

BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%

... Read more

BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%

... Read more

BioSyent Releases Q4 and

... Read more

BioSyent Releases First Six

... Read more

BioSyent Releases First Six

... Read more

BioTime’s Subsidiary

... Read more